Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 9/20 | 0.63 |
| ▸ | ACE | P12821 | 6/20 | 0.63 |
| ▸ | CYP26A1 | O43174 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8453630 | 0.91 | MME (0.51) | MMEACECYP26A1 | |
| SCHEMBL8447368 | 0.90 | MME (0.58) | MMEACECYP26A1SMN1; SMN2KMT2A | |
| SCHEMBL8451301 | 0.89 | MME (0.50) | MMEACECYP26A1SMN1; SMN2 | |
| SCHEMBL8451866 | 0.89 | MME (0.50) | MMEACECYP26A1SMN1; SMN2KMT2A | |
| SCHEMBL8455915 | 0.87 | MME (0.48) | MMEACECYP26A1SMN1; SMN2KMT2A | |
| SCHEMBL8447366 | 0.85 | MME (0.47) | MMEACECYP26A1SMN1; SMN2KMT2A | |
| SCHEMBL8448568 | 0.83 | MME (0.63) | MMEACE | |
| SCHEMBL8453402 | 0.81 | MME (0.47) | MMEACECYP26A1SMN1; SMN2 | |
| SCHEMBL8447834 | 0.81 | CYP26A1 (0.45) | MMEACECYP26A1SMN1; SMN2 | |
| SCHEMBL8523066 | 0.80 | MME (0.49) | MMEACEKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5891912-A | ENDOPEPTIDASE 24.11 INHIBITORS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1999-04-06 | — | — | US | disclosed |